References
- Harris M. C. Serotonin. Its possible relationship to allergic disease. Cal. Med. 1959; 9: 68
- Waalkes T. P., Cobukn H. The role of platelets and the release of serotonin and histamine to anaphylaxis in the rabbit. J. Allergy 1950; 30: 394
- O'Brien D. J., Hughes F. W., Newberne J. Influence of lysergic acid diethylamide on experimental allergic encephalomyelitis (27832). Soc. for Exp. Biol, and Med. 1962; 111: 490
- Cerletti A., Doepfner W. Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids. J. Pharrn. Exp. Therap. 1958; 122: 124, Cerletti, A., Schlager, E., Spitzer, F., and Taeschler, M., ed., Psycho-pharmaka Med. und Pharm. Shweiz. Apoth. -Ztg. 101, 210 (1963).
- Abramson H. A., Rolo A. Lysergic acid diethylamide (LSD): XXIX. The re- sponse index as a measure of the threshold activity of psychotic drugs in man. J. Psychol 1959; 48: 65
- Abramson H. A., Role A., Sklarofsky B., Stache J. Production of cross-toler- ance to psychosis-producing doses of lysergic and diethylamide and psilocybin. J. Psychol. 1960; 49: 151, Abramson, H. A., Sklarofsky, B., Baron, M. O., and Free-mont-Smith, F.;, Lysergic acid diethylamid (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl d-lysergic acid diethylamide). Arch. Neurol., & Psychiai. 79, 201 (1958). Abramson, H. A., Hewitt, M. P., Lennard, H., Turner, W. J., O'Neil, F. J. and Merlis, S. Lysergic acid diethylamide (LSD-25): XXIV. The stablemate concept of therapy as affected by LSD in schizophrenia. J. Psychol. 45, 75 (1958). Abramson, H. A., Ed. The Use of LSD in Psychotherapy, Josiah H. Macy, Foundation, N. Y. (1959).
- Dalessio D. J. On migraine headache: serotonin and serotonin antagonism. JAM A. 1962; 181: 318, Friedman, A. P. and Elkind, A. H. Appraisal of methysergide in treatment of vascular headaches of migraine type. J.A.M.A. 184, 125 (1963). Graham, J. R. Methysergide for prevention of headache. Experience of five hundred patients over three years.
- Cohen S. Lysergic acid diethylamide: side effects and complications. J. Ner. and Ment. Dis. 1960; 130: 30
- Ditman K. S., Hayman M., Whittlesey J. R. B. Nature and frequency of claims following LSD. J. Nerv. and Ment. Dis. 1962; 134: 346
- Hofmann A. Chemical, Pharmacological and medical aspects of psychotomimetics. J. Exp. Med. Sci. 1961; 5: 31
- Sandison R. A. In Hallucinogenic drugs and their psychogenic use, R. Crockett, R. A. Sandison, A. Walk. Chas. C Thomas, Springfield 1964; 111
- The Use of LSD in Psychotherapy, H. A. Abramson, Josiah. Macy, Jr. Foundation, NY 1959
- Bender L., Goldschmidt L., Sankar D. V. S. Treatent of autistic schizophrenic children with LSD-25 and UML-491. Recent Advances in Biological Psychiatry 1962; 4: 170, Bender, L., Faretra, G. and Cobrinik, L.; LSD and UML treatment of hospitalized disturbed children. Recent Advances in Biological Psychiatry, 5:84 (1963)
- Abstracted from a report in Clinical Trends. August, 1964